The new highly sensitive adrenocorticotropin assay improves detection of patients with partial adrenocorticotropin deficiency in a short-term metyrapone test.
This study was designed to evaluate a short term metyrapone test using a highly sensitive (HS) IRMA ACTH assay and to evaluate the usefulness of a morning ACTH level as a screening test for partial ACTH deficiency. ACTH, 11-deoxycortisol and cortisol levels were evaluated over four hours in the morning after a single 40 mg/kg oral dose of metyrapone was administered at 0800 hours. 26 control children and 32 possibly pituitary deficient patients were evaluated. Based on 11-deoxycortisol levels alone, 17 of the patients passed the test, 11 patients failed the test and the result was inconclusive in four patients (12.5%). Evaluation of the increase in ACTH levels (delta ACTH) following metyrapone identified three of the above four with partial ACTH deficiency. The delta ACTH was consistent with the 11-deoxycortisol results in the remainder of patients. There was no difference in morning ACTH levels between controls and patients with partial ACTH deficiency. The measurement of ACTH using the HS IRMA assay, increases the sensitivity of the metyrapone test in detecting patients with partial ACTH deficiency. This test may be used safely in pediatric patients on a repetitive basis, especially in those children who may have progressive ACTH failure following hypothalamic-pituitary irradiation.
Thornton
P S
PS
Department of Endocrinology and Diabetes, Children's Hospital of Philadelphia, University of Pennsylvania 19104, USA.
Alter
C A
CA
Katz
L E
LE
Gruccio
D A
DA
Winyard
P J
PJ
Moshang
T
T
D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000097:blood* / Q000172:deficiency*; D000328:Adult; D002648:Child; D002675:Child, Preschool; D003350:Cortodoxone / Q000097:blood; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D015592:Immunoradiometric Assay; D007223:Infant; D008297:Male; D008797:Metyrapone / Q000009:adverse effects; D010911:Pituitary Neoplasms / Q000150:complications / Q000532:radiotherapy
D000324:Adrenocorticotropic Hormone; D003350:Cortodoxone; D006854:Hydrocortisone; D008797:Metyrapone